Published in Life Sci on May 25, 2007
Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther (2011) 1.62
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol (2012) 1.42
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol (2009) 1.41
Promoter methylation and the detection of breast cancer. Cancer Causes Control (2009) 1.18
Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol (2011) 1.13
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response. J Mammary Gland Biol Neoplasia (2010) 1.02
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer (2013) 1.01
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. Cancer Epidemiol Biomarkers Prev (2009) 0.99
DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer Res (2014) 0.98
DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol (2010) 0.98
Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer. BMC Cancer (2010) 0.96
Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res (2008) 0.95
Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer. PLoS One (2013) 0.95
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer. BMC Cancer (2013) 0.91
Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics (2010) 0.90
BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression. Virchows Arch (2012) 0.89
5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes. PLoS One (2012) 0.87
Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients. Adv Biomed Res (2012) 0.87
Hypoxia and DNA repair. Yale J Biol Med (2013) 0.86
Epigenetic Signatures in Breast Cancer: Clinical Perspective. Breast Care (Basel) (2010) 0.86
Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients. Virchows Arch (2011) 0.83
Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients. Clin Cancer Res (2011) 0.81
DNA methylation and apoptosis resistance in cancer cells. Cells (2013) 0.79
Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics (2016) 0.78
Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis. Clin Exp Med (2012) 0.78
DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification. EXCLI J (2016) 0.78
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes. PLoS One (2015) 0.77
Promoter hypermethylation of estrogen receptor alpha gene is correlated to estrogen receptor negativity in Iranian patients with sporadic breast cancer. Cell J (2012) 0.76
Role of epigenetic modifications in luminal breast cancer. Epigenomics (2015) 0.76
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res (2016) 0.75
Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients. Int J Breast Cancer (2016) 0.75
Observations on the presence of E domain variants of estrogen receptor-alpha in the breast tumors. J Surg Oncol (2006) 1.43
Principles of physics in surgery: the laws of mechanics and vectors physics for surgeons-part 2. Indian J Surg (2010) 1.41
Treatment of non-union of humerus diaphyseal fractures: a prospective study comparing interlocking nail and locking compression plate. Arch Orthop Trauma Surg (2014) 1.39
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer (2009) 1.29
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
Splenic rupture complicating aortic valve replacement for bacterial endocarditis. Interact Cardiovasc Thorac Surg (2007) 1.17
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci (2007) 1.17
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head Neck Oncol (2009) 1.16
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res (2008) 1.14
Infant feeding practices in the rural population of north India. J Family Community Med (2012) 1.10
Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer (2007) 1.09
MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology (2005) 1.07
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat (2006) 1.06
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology (2008) 1.06
Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One (2010) 1.04
Homocysteine- and cysteine-mediated growth defect is not associated with induction of oxidative stress response genes in yeast. Biochem J (2006) 1.04
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci (2010) 1.04
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer (2009) 1.03
Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci (2008) 1.03
Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. PLoS One (2013) 1.02
Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed (2010) 1.02
Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications. Microsc Res Tech (2003) 1.02
Peritonitis: 10 years' experience in a single surgical unit. Trop Gastroenterol (2008) 1.01
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res (2005) 1.01
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer (2013) 1.01
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res (2008) 1.00
Centchroman regresses mastalgia: a randomized comparison with danazol. Indian J Surg (2010) 1.00
Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev (2002) 0.99
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer (2013) 0.99
Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact (2009) 0.99
Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics (2006) 0.97
Factors influencing wound infection following laparoscopic cholecystectomy. Trop Gastroenterol (2003) 0.96
14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets (2012) 0.96
Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg (2004) 0.96
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol (2009) 0.96
Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer (2003) 0.95
Small interfering RNA targeting 14-3-3ζ increases efficacy of chemotherapeutic agents in head and neck cancer cells. Mol Cancer Ther (2010) 0.94
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology (2005) 0.94
Role of centchroman in regression of mastalgia and fibroadenoma. World J Surg (2007) 0.94
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem (2009) 0.94
An unusual presentation of biloma five years following cholecystectomy: a case report. Cases J (2009) 0.94
Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer (2007) 0.93
Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2003) 0.93
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer (2009) 0.92
Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett (2006) 0.92
Radiographic evaluation of dental age of adults using Kvaal's method. J Forensic Dent Sci (2010) 0.92
Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer (2010) 0.92
Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck (2011) 0.91
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol (2010) 0.91
Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence. PLoS One (2013) 0.90
Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray. Int J Cancer (2007) 0.90
Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents. Mol Cell Biochem (2010) 0.89
Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One (2011) 0.89
Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma. Cancer Invest (2010) 0.89
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. Tumour Biol (2012) 0.88
An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma. PLoS One (2012) 0.88
14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells. BMC Cancer (2010) 0.88
Isoniazid-induced apoptosis in HepG2 cells: generation of oxidative stress and Bcl-2 down-regulation. Toxicol Mech Methods (2010) 0.87
Clinical significance of TC21 overexpression in oral cancer. J Oral Pathol Med (2009) 0.87
Evanescent tunneling of an effective surface plasmon excited by convection electrons. Phys Rev Lett (2007) 0.87
TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncology (2005) 0.87
Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck (2009) 0.86
Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells. Carcinogenesis (2010) 0.86
Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer. Int J Cancer (2007) 0.86
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer (2012) 0.86
Secretome-based identification and characterization of potential biomarkers in thyroid cancer. J Proteome Res (2010) 0.85
Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. Oral Oncol (2003) 0.85
Giant myofibroblastoma of the male breast: a case report and literature review. Malays J Med Sci (2012) 0.85
Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. Clin Biochem (2009) 0.84
Evaluation of human LOX-12 as a serum marker for breast cancer. Biochem Biophys Res Commun (2011) 0.84
Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients. Ann Surg Oncol (2012) 0.84
MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol (2006) 0.84